Up-regulation of S100A4 Expression by HBx Protein Promotes Proliferation of Hepatocellular Carcinoma Cells and Its Correlation with Clinical Survival.

Kai Zhu,Wenwen Huang,Wenju Wang,Liwei Liao,Shuo Li,Songlin Yang,Jingyi Xu,Lin Li,Mingyao Meng,Yanhua Xie,Shan He,Weiwei Tang,Haodong Zhou,Luxin Liang,Hui Gao,Yiyi Zhao,Zongliu Hou,Jing Tan,Ruhong Li
DOI: https://doi.org/10.1016/j.gene.2020.144679
IF: 3.913
2020-01-01
Gene
Abstract:Background: Hepatocellular carcinoma is one of the most common cancers worldwide. HBV-related HCC has characteristics of faster progression and worse prognosis. Previous studies have confirmed that HBx protein plays numbers of important roles in development of HBV-HCC. However, the molecular mechanism of carcinogenicity of HBx is still not well documented. Methods: Firstly, a HCC cell line over-expressing HBx was established and its function was verified. Subsequently, the differentially expressed genes were detected by transcriptome sequencing technology and use the Western Blot technology to detect the up-regulated genes in HBx over-expressed cells, and the functional correlation of the genes was analyzed. Finally, tissue microarray was used to correlate up-regulated gene with clinical follow-up data to verify correlation with clinical prognosis. Results: Over-expression of HBx could promote cell proliferation, and over-expression of HBx could up-regulate the expression of S100A4 protein. ShRNA experiments showed that HBx promoted cell proliferation by upregulating the expression of S100A4. IFN-alpha 2b can down-regulate the expression of S100A4 and inhibit the proliferation of HCC cells. The expression of S100A4 in cancer was significantly up-regulated compared with adjacent tissues, and was also significantly associated with tumors volume, the expression of PD-L1 and the survival time of patients with HCC. Conclusion: In general, S100A4 may be an effective therapeutic target for HBV-HCC. And the connection between S100A4 and HBV are not clear yet. This study may play a guiding role in the future clinical treatment of HCC.
What problem does this paper attempt to address?